Communities across Asia's Himalayan Hindu Kush region face heightened disaster risks this monsoon season with temperatures ...

A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...

Wildlife rescue teams scoured Australia's east coast on Monday to find and free a distressed humpback whale tangled in a rope ...

Weight-loss drugs are already dropping in price; could they go even lower? - Consumers are now able to pay roughly $500 for the drugs, which often retail at more than $1,000 ...

100% of the fees we collect are used to support our nonprofit mission. Learn more. O bstructive sleep apnea (OSA), marked by numerous pauses in breathing during sleep, can cause daytime ...

like sleep apnea." Hill also points out that smokers feel the stimulating effect of nicotine differently to other tobacco users. "Smoking tobacco delivers nicotine to the bloodstream at a faster ...

Former Grizzlies forward Chandler Parsons and current Atlanta Hawks forward Georges Niang appeared on FanDuel TV's "Run It Back" to debate which of the two players they would start a team with.

When it comes to the future of the College Football Playoff, there were as many opinions as there were coaches on hand at the Southeastern Conference and Big 12 meetings in Florida this week. Perhaps ...

Donation Options Search Search Search Boxes of the weight-loss medications Wegovy and Zepbound. JoNel Aleccia / AP Share Excess body weight can raise the risk of certain cancers. So researchers ...

After Nick Saban announced his retirement from college football following the 2023 season, only four coaches who had won a national championship remained active in college football. However ...

Over the past few years, demand for blockbuster medications like Ozempic, Wegovy and Zepbound skyrocketed. These drugs are typically prescribed to address a range of health issues, including ...

Credit: Getty Images With the FDA approval of Zepbound (tirzepatide) for obstructive sleep apnea, GLP-1 receptor agonists harbor potential beyond weight and diabetes management. In recent years ...